Recombinant Full Length Danio Rerio Apelin Receptor B(Aplnrb) Protein, His-Tagged

• Cat.No.: RFL33896DF
• Product Overview: Recombinant Full Length Danio rerio Apelin receptor B(aplnrb) Protein (A0T2N3) (1-359aa), fused to N-terminal His tag, was expressed in E. coli.

Specification

• Source: E.coli expression system
• Species: Danio rerio (Zebrafish) (Brachydanio rerio)
• Tag: His
• Form: Lyophilized powder
• Protein Length: Full Length (1-359)
• AA Sequence: MNAMDNMTADYSPDYFDDAVNSSMC EYDEWEPSYSLIPVLYMLIFILGLT GNGVVIFTVW RAQSKRRAADVYIGNLALADLTFVV TLPLWAVYTALGYHWPFGVALCKIS SYVVLLNMYA SVFCLTCLSLDRYMAIVHSLTSTQL RTRGHMRASLTAIWLLSGVLAAPTL LFRTTVYDVE TNRTSCAMDFNLVVSQPGQETYWIA GLSISSTALGFLIPLLAMMVCYGFI GCTVTRHFNS LRKEDQRKRRLLKIITTLVVVFAAC WMPFHVVKTMDALSYLNLAPDSCTF LNLLLLAHPY ATCLAYVNSCLNPLLYAFFDLRFRS QCLCLLNLKKALHASPASSLSSQKT EAQSLATKV
• Purity: Greater than 90% as determined by SDS-PAGE.
• Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
• Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
• Storage Buffer: Tris/PBS-based buffer, 6% Trehalose, pH 8.0
• Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
• Gene Name: aplnrb
• Synonyms: aplnrb; agtrl1b; grn; zgc:114063; Apelin receptor B; Angiotensin II receptor-like 1b; Angiotensin receptor-like 1b; G-protein coupled receptor APJ B; Protein grinch
• UniProt ID: A0T2N3

Gene Information

• Gene Name: aplnrb
• Synonyms: aplnrb; agtrl1b; grn; zgc:114063; Apelin receptor B; Angiotensin II receptor-like 1b; Angiotensin receptor-like 1b; G-protein coupled receptor APJ B; Protein grinch
• UniProt ID: A0T2N3

Reviews

12/30/2021

APLNRB has a very high environmental awareness and an immeasurable contribution to the environment.

10/19/2021

Consistent high performance can be maintained every time it is used, proving that the production process is very careful.

04/13/2021

Simple and convenient operation, greatly reduce human error.

10/15/2020

If it is stored for a long time, it will not affect its performance.

Q&As

How does APLNRB affect cardiovascular disease?

APLNRB may affect cardiovascular health by binding to its receptors and regulating a range of signaling pathways associated with cardiovascular disease.

What are the applications of APLNRB in scientific research?

APLNRB has been widely used in scientific research, which can be used to study its role in cell signaling pathway, development, disease and so on.

What is the mechanism of APLNRB repair damage?

The mechanism by which APLNRB recovers damage is still unclear, and further studies are needed to answer this question.

Can APLNRB promote tissue repair?

There is no definitive evidence that APLNRB s promote tissue repair, but this is an interesting line of research.

How is APLNRB prepared?

APLNRB is produced by introducing APLNRB gene into host cells, and then using cellular mechanisms to express and prepare it.

What is APLNRB ?

APLNRB (APLNRB ) is a protein associated with the APLNRB receptor produced by genetic engineering.

Which diseases are APLNRB s associated with?

APLNRB s are being studied in relation to a variety of diseases, such as cardiovascular disease, cancer, and neurological diseases. However, the relationship between specific diseases and APLNRB s still needs to be confirmed by further studies.

What is the relationship between APLNRB and neurological diseases?

APLNRB may be involved in the occurrence and development of neurological diseases, but further studies are needed to determine the specific mechanism.

What is the relationship between APLNRB and APLNRB receptor?

APLNRB s bind to APLNRB receptors and can be used as active or antagonistic ligands to mimic or inhibit APLNRB signaling pathways.

What is the prospect of APLNRB in clinical practice?

Because the research of APLNRB in clinical practice is not enough, its potential clinical prospect needs to be further explored by future scientific research.

Can APLNRB be used in gene therapy?

APLNRB has not yet been shown to be useful in gene therapy, but it is an area worth continuing research.

Does APLNRB have anti-inflammatory effects?

There is no clear evidence that APLNRB s have anti-inflammatory effects, but this is also an area of research.

Are there any related products of APLNRB already on the market?

At present, there are no products on the market about APLNRB , but there may be suppliers in the scientific research field to provide kits and other related products.

Are there side effects of APLNRB ?

There have been no reports of side effects of APLNRB , but a large number of animal experiments and clinical trials are usually required to ensure its safety before clinical use.

Can APLNRB be used to prepare drugs?

APLNRB may serve as a potential candidate for drug preparation, but more research is needed to verify its feasibility for drug development.

Does APLNRB have an effect on the immune system?

Regarding the effect of APLNRB on the immune system, there is not enough research data to support or disprove this question.

What progress has been made in the study of the biological importance of APLNRB ?

Research on the biological importance of APLNRB has made some progress, but more experimental validation and clinical data are needed to determine its precise biological function.

What is the clinical application of APLNRB ?

APLNRB is rarely used in clinical practice, but it is widely used in scientific research, which can be used to study the function of APLNRB receptor and its role in disease.

Can APLNRB be used to treat cancer?

APLNRB has not yet been proven to be useful in cancer treatment, but researchers are trying to explore new ways of cancer treatment by regulating the APLNRB signaling pathway.